Source: ThinkstockIn our previous looks at big bank stocks going into the new year, the two that appear to be best positioned for growth were Citigroup Inc. (NYSE: C) and JPMorgan Chase & Co. (NYSE: JPM). The analysts at Sterne Agee have reached the same conclusion regarding big banks, and the analysts have also taken a closer look at regional and multinational banks.
Here�� their conclusion:
Asset-sensitive regional banks provided the catalyst for the sector�� outperformance in ’13. However, as we enter ��4, we see few catalysts to drive sector performance meaningfully higher as earnings expectations slow dramatically to a mid single-digit pace. No doubt, the operating environment remains challenging, but as the economy continues to grind forward, our sense is the banking sector stands to post further, albeit modest gains in ��4.
Top Defensive Stocks To Watch Right Now: Navidea Biopharmaceuticals Inc (NAVB)
Navidea Biopharmaceuticals, Inc. (Navidea), formerly Neoprobe Corporation, incorporated in 1983, is a biopharmaceutical company focused on the development and commercialization of precision diagnostic agents. As of December 31, 2011, the Company�� radiopharmaceutical development programs included Lymphoseek (Lymphoseek, Kit for the Preparation of Technetium Tc99m for Injection), a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent, and RIGScan, a tumor antigen-specific targeting agent. In January 2012, the Company executed an option agreement with Alseres Pharmaceuticals, Inc. (Alseres) to license [123I]-E-IACFT Injection, also called Altropane, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson�� disease, movement disorders and dementia. In August 2011, the Company sold its gamma detection device line of business (the GDS Business) to Devicor Medical Products, Inc.
Lymphoseek
Navidea�� pipeline includes clinical-stage radiopharmaceutical agents used to identify the presence and status of disease. Lymphoseek (Kit for the Preparation of Technetium Tc99m for Injection) is a lymph node targeting agent intended for use in intraoperative lymphatic mapping (ILM) procedures and lymphoscintigraphy employed in the overall diagnostic assessment of certain solid tumor cancers. The lymph system is a component of the body�� immune system. The key components of the lymph system are lymph nodes-small anatomic structures that contain disease-fighting lymphocytes, filter lymph of bacteria and cancer cells, and signal infection in response to heightened levels of pathogens. In Navidea�� Phase III clinical studies of Lymphoseek, it detected over 99% of positive nodes identified by vital blue dye (VBD). As of December 31, 2011, Navidea, in co-operation with UC, San Diego affiliate (UCSD), completed or initiated five Phase I clinical trials, one multi-center Phase II trial and three multi-center Phase II trials inv! olving Lymphoseek. Two Phase III studies were completed in subjects with breast cancer and melanoma. During the year ended December 31, 2011, data from NEO3-09 were released, which indicated that all primary and secondary endpoints for the study were met. As of December 31, 2011, third Phase III clinical trial for Lymphoseek in subjects with head and neck squamous cell carcinoma (NEO3-06) was in progress.
AZD4694
AZD4694 is a Fluorine-18 labeled precision radiopharmaceutical candidate for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer's disease (AD). It binds to beta-amyloid deposits in the brain that can then be imaged in positron emission tomography (PET) scans. Amyloid plaque pathology is a required feature of AD and the presence of amyloid pathology is a supportive feature for diagnosis of probable AD. Patients who are negative for amyloid pathology do not have AD. AZD4694 has been studied in several clinical trials. Clinical studies through Phase IIa have included more than 80 patients to date, both suspected AD patients and healthy volunteers. No significant adverse events have been observed. Results suggest that AZD4694 has the ability to image patients quickly and safely with high sensitivity.
RadioImmunoGuided Surgery
As of December 31, 2011, RIGScan had been studied in a number of clinical trials, including Phase III studies. Navidea has conducted two Phase III studies, NEO2-13 and NEO2-14, of RIGScan in patients with primary and metastatic colorectal cancer, respectively. Both studies were multi-institutional involving cancer treatment institutions in the United States, Israel, and the European Union.
The Company competes with Pharmalucence, Eli Lilly, Bayer Schering, General Electric and GE Healthcare.
Advisors' Opinion:- [By Lauren Pollock]
Navidea Biopharmaceuticals Inc.(NAVB) said the U.S. Food and Drug Administration has granted a priority review for an expanded use of its Lymphoseek drug for some patients with head and neck cancer. Shares dropped 5.4% to $1.97 premarket.
- [By Lauren Pollock]
Among the companies with shares expected to actively trade in Tuesday’s session are Toll Brothers Inc.(TOL) and Navidea Biopharmaceuticals Inc.(NAVB)
- [By Keith Speights]
3. Navidea Biopharmaceuticals (NYSEMKT: NAVB )
Some investors were likely befuddled by Navidea's stock action earlier this year. The company received FDA approval in March for Lymphoseek, its radiopharmaceutical agent used for imaging lymph nodes in patients with breast cancer or melanoma. That was great news, but shares dropped quickly and still haven't returned to previous levels.
Top 5 Regional Bank Stocks To Buy For 2014: Flowers Foods Inc (FLO)
Flowers Foods, Inc. (Flowers Foods), incorporated in October 2000, is a producer and marketer of bakery products in the United States. The Company is the producer and marketer of packaged bakery foods for retail and foodservice customers in the United States. Flowers Foods operates 44 bakeries that produce a range of bakery products, which include breads, buns, rolls, snack cakes, and pastries. These products are sold through a direct-store-delivery network with access to approximately 70% of the United States population in the East, South, and Southwest, as well as in certain markets in California. Select Flowers products are sold nationwide through customers' delivery systems. Among the Company�� top brands are Nature�� Own and Tastykake. The Company has two business segments: direct-store-delivery (DSD segment) and warehouse delivery segment (warehouse segment). In May 2011, the Company acquired Tasty Baking Company. In July 2012, it acquired Lepage Bakeries, Inc.
The DSD segments focuses on the production and marketing of bakery products to United States customers in the Southeast, Mid-Atlantic, Northeast and Southwest, as well as select markets in California and Nevada primarily through its DSD system. The warehouse segment produces snack cakes and breads and rolls that are shipped both fresh and frozen to national retail, foodservice, vending, and co-pack customers through their warehouse channels. The Company�� brands include Whitewheat, Cobblestone Mill, Blue Bird, ButterKrust, Dandee, Mary Jane, and Mary Jane and Friends. During the year ended December 31, 2011, it introduced the new products under this brand, including Nature�� Own Whitewheat Sandwich Rounds; Nature�� Own Whole Grain Sandwich Rolls and Hot Dog Rolls; Nature�� Own Cinnamon Raisin Thin Sliced Bagels; Nature�� Own Soft Oatmeal Specialty Bread; Nature�� Own 100% Whole Grain Specialty Bread, and Nature�� Own Honey Wheat Berry Specialty Bread. In addition to Nature�� Own, its DSD segment also marke! ts: a range of specialty breads and rolls under the Company-owned Cobblestone Mill brand; white breads and buns under regional company owned and franchised brands, such as Sunbeam, Bunny, Aunt Hattie��, Holsum, and ButterKrust; Tastykake and Blue Bird branded snack cakes and pastries; flour, white, and corn tortillas under the Mi Casa and Frestillas brands, and fresh packaged bakery products under store brands for retailers.
The Company�� warehouse segment markets a range of specialty breads and rolls under the European Bakers brand, breads, buns, and rolls for specific foodservice customers, and tortillas and tortilla chips under Leo�� Foods and Juarez. This segment�� snack cakes are sold under the Mrs. Freshley��, Broad Street Bakery, and store brands. Its warehouse segment products are distributed nationally through retail, foodservice and vending customer warehouses.
The Company competes with Grupo Bimbo S.A. de C.V./Bimbo Bakeries, Hostess Brands, Inc., Sara Lee Corporation, Campbell Soup Company, McKee Foods Corporation, Cloverhill Bakery, Hostess Brands, Inc., Alpha Baking Co., Inc., Rotella�� Italian Bakery, United States Bakery, Turano Baking Company and All Round Foods, Inc.
Advisors' Opinion:- [By Caroline Bennett]
The board of directors for Flowers Foods (NYSE: FLO ) announced a three-for-two stock split at the annual shareholders meeting this week and increased the total annual cash dividend by $0.035.
- [By Laura Brodbeck]
Thursday
Earnings Expected From: Wal-Mart (NYSE: WMT), Nordstrom (NYSE: JWN), Kohl�� (NYSE: KSS), Flowers Foods (NYSE: FLO) Economic Releases Expected: �US industrial production, US CPI, eurozone GDP, eurozone CPI, German GDP, French GDPFriday
- [By Dan Caplinger]
Tomorrow, Flowers Foods (NYSE: FLO ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed, knee-jerk reaction to news that turns out to be exactly the wrong move.
- [By Dividend]
Flowers Foods (FLO) has a market capitalization of $4.59 billion. The company employs 9,800 people, generates revenue of $3,046.49 million and has a net income of $136.12 million. Flowers Foods�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $328.30 million. The EBITDA margin is 10.78 percent (the operating margin is 7.17 percent and the net profit margin 4.47 percent).
Top 5 Regional Bank Stocks To Buy For 2014: M/A-COM Technology Solutions Holdings Inc (MTSI)
M/A-COM Technology Solutions Holdings, Inc. (M/A-COM), incorporated on March 25, 2009, is a provider of high-performance analog semiconductor solutions for uses in wireless and wireline applications across the radio frequency (RF), microwave and millimeter wave spectrum. The Company manages has one segment, which is semiconductors. The Company offers over 2,700 standard and custom devices, which includes integrated circuits (IC), multi-chip modules, power pallets and transistors, diodes, switches and switch limiters, passive and active components and complete subsystems, across 37 product lines serving over 6,000 end customers in four primary markets. The Company's semiconductor products are electronic components that the Company's customers incorporate into their larger electronic systems, such as point-to-point wireless backhaul radios, radar, automobile navigation systems, digital cable television (CATV) set-top boxes, magnetic resonance imaging systems and unmanned aerial vehicles. In February 2014, M/A-COM Technology Solutions Holdings Inc announced that its subsidiary Mindspeed Technologies Inc completed the sale of assets of its wireless infrastructure business unit to Intel Corporation.
The Company's primary markets are Networks, which includes CATV, cellular backhaul, cellular infrastructure and fiber optic applications; Aerospace and Defense (A&D); Automotive, which includes global positioning system (GPS) modules sold to the automotive industry; and Multi-market, which includes industrial, medical, mobile communications and scientific applications. The Company operates a single Gallium Arsenide (GaAs) and silicon semiconductor fab at its Lowell, Massachusetts headquarters, which the Company is in the process of updating to include Gallium Nitride (GaN) fabrication operations as well. The Company also utilizes external semiconductor foundries to supply the Company with additional capacity in periods of high demand and to provide the Company access to additional process technolog! ies. The ability to utilize a broad array of internal process technologies as well as commercially available foundry technologies allows the Company to select the appropriate technology to solve the Company's customers' needs.
The Company offers high-performance analog semiconductor products for both wireless and wireline applications across the frequency spectrum from RF to millimeterwave. The Company regularly develops high-value products to serve its customers in four primary markets: Networks, A&D, Multi-market and Automotives.
Aerospace & Defense
In the A&D market, military applications require more advanced electronic systems, such as radar warning receivers, communications data links and tactical radios, unmanned aerial vehicles (UAVs), RF jammers, electronic countermeasures and smart munitions. Military applications are becoming more sophisticated, favoring higher performance semiconductor ICs based on GaAs and GaN technology due to their high power density, improved power efficiency and broadband capability. Radar systems for mapping and targeting missions are undergoing a transition from existing mechanically-scanned radar products to a new generation of active electronically-scanned array (AESA) based products. Consisting of hundreds or thousands of transmit/receive modules commonly based on GaAs and increasingly on GaN technology, AESAs deliver greater speed, range, resolution and reliability over mechanically-scanned radar products that utilize a single transmitter and receiver with mechanical steering. Military communications employing wireless infrastructure and tactical radios in the field remain critical for allowing geographically dispersed users to exchange information quickly and efficiently. UAVs and their underlying semiconductor content requires designs to meet rigorous specifications for high performance, small size, and low power consumption.
Automotive
The Automotive category includes GPS modules the Company sel! ls to the! automotive industry. Semiconductor content in automobiles is projected to grow in order to offer connectivity, safety, performance and navigation features.
Multi-market
In Multi-market, the Company's products are used in industrial, medical, mobile communications, test and measurement and scientific applications. In the medical industry, the Company's custom designed non-magnetic diode product line is a critical component for certain MRI applications. The Company offers a broad range of standard and custom ICs, modules and complete subsystems across 37 product lines. The Company's product portfolio consists of more than 2,700 products including the key product platforms: power pallets and transistors, ICs, diodes, switches and switch limiters, passive and active components, multi-chip modules, and complete subsystems. Many of the Company's product platforms are leveraged across multiple markets and applications. For example, the Company's applications with regard to power transistor technology is leveraged across both scientific laboratory equipment applications and commercial and defense radar system applications. The Company's diode technology is used in switch filter banks of military tactical radios as well as medical imaging MRI systems.
The Company competes with Hittite Microwave Corporation, Sumitomo Electric Device Innovations, Inc., RF Micro Devices, Inc. (RFMD), Avago, Inc. (Avago), Aeroflex, Inc. (Aeroflex), Microsemi Corporation (Microsemi), TriQuint and Skyworks Solutions, Inc.
Advisors' Opinion:- [By Lauren Pollock]
M/A-COM Technology Solutions Holdings Inc.(MTSI) agreed to acquire semiconductor manufacturer Mindspeed Technologies Inc.(MSPD) in a deal valued at $272 million, expanding the company’s markets to include enterprise applications. Mindspeed shares surged 70% to $5.04 premarket.
Top 5 Regional Bank Stocks To Buy For 2014: Pound/Rand(PX)
Praxair, Inc. engages in the production, distribution, and sale atmospheric and process gases, as well as surface coatings in North America, Europe, South America, and Asia. The company offers atmospheric gases, such as oxygen, nitrogen, argon, and rare gases; and process gases comprising carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene. It also designs, engineers, and builds equipment that produces industrial gases; and manufactures precious metal and ceramic sputtering targets used primarily in the production of semiconductors. In addition, the company supplies surface coatings consisting of wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders to the aircraft, energy, printing, textile, plastics, primary metals, petrochemical, and other industries. Further, it provides electric arc, plasma, and oxygen fuel spray equipment, as well as arc and flame wire equipment used for the application of wea r-resistant coatings; and distributes welding equipment purchased from independent manufacturers. The company sells its products primarily through independent distributors. It serves various industries, such as healthcare, petroleum refining, computer-chip manufacturing, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, and water treatment industries. The company was founded in 1907 and is headquartered in Danbury, Connecticut.
Advisors' Opinion:- [By Marc Bastow]
Industrial gasses supplier Praxair (PX) raised its quarterly dividend 8% to 65 cents per share, payable on Mar. 17 to shareholders of record as of Mar. 7.
PX Dividend Yield: 2.08% - [By Ben Levisohn]
As a reminder, Air Products & Chemicals was in the low $90s when activist Bill Ackman told investors in July 2013 that he had taken a major position in a large-cap, investment-grade US corporation. Since then Air Products & Chemicals has closed its valuation gap with Praxair (PX), although restructuring has been limited so far.
- [By Jonas Elmerraji]
It doesn't get any more straightforward than what's going on in shares of industrial gas supplier Praxair (PX). Praxair has been bouncing higher in an uptrending price channel since all the way back in April, which is creating a buyable opportunity in shares this week.
The uptrending channel in Praxair has done a good job of defining the high-probability range for shares since that time. Logically, then, it makes sense to become a buyer as close to trendline support as possible; in short, you want to "buy the bounce." And shares are certainly bouncing now.
Buying off a support bounce makes sense for two big reasons: it's the spot where shares have the furthest to move up before they hit resistance, and it's the spot where the risk is the least (because shares have the least room to move lower before you know you're wrong). Remember, all trend lines do eventually break, but by actually waiting for the bounce to happen first, you're ensuring PX can actually still catch a bid along that line.
The 50-day moving average has been a good proxy for support lately, so it's a solid place to put a protective stop if you decide to be a buyer at this point.
No comments:
Post a Comment